Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00147-9/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=263719363&_hsenc=p2ANqtz-9ApCojh7RrMPbBErrs3P0IaqXpKFrWMnhgdHbf-9BI9foTGGu0CPCVExCX_AunTRwK6wmQZZ8JuC1ygD_l1Jga1_pLmg&utm_content=263697128&utm_source=hs_email